Eli Lilly LLY
NYSE LLY
$1,143.30 -6.79 (-0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Eli Lilly (LLY) posted Return on Capital Employed [ROCE] of 46.74% for Q2 2026, up 7.58 percentage points from 39.15% a year earlier and up 3.80 percentage points from the prior quarter.

Analysis

Eli Lilly (LLY) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Eli Lilly's Return on Capital Employed [ROCE] came in at 48.39%, up 10.75 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for five consecutive years, with a five-year change of +25.99 percentage points (FY2020 to FY2025).
  • In prior years, Eli Lilly's Return on Capital Employed [ROCE] was 37.64% in FY2024 (+2.82 pp), 34.82% in FY2023 (+9.72 pp), 25.10% in FY2022 (+2.67 pp) and 22.43% in FY2021 (+0.03 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2010.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last 12 quarters, with an average year-over-year change of +6.32 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 10.02 percentage points; the weakest was Q2 2023, with a drop of 5.75 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 42.94% (Q1 2026), 37.22% (Q4 2025) and 37.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 20.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.74%
Mar 31, 2026 42.94%
Dec 31, 2025 37.22%
Sep 30, 2025 37.83%
Jun 30, 2025 39.15%
Mar 31, 2025 34.87%
Dec 31, 2024 33.16%
Sep 30, 2024 28.23%
Jun 30, 2024 31.69%
Mar 31, 2024 24.85%
Dec 31, 2023 30.47%
Sep 30, 2023 27.13%
Jun 30, 2023 21.77%
Mar 31, 2023 20.00%
Dec 31, 2022 25.64%
Sep 30, 2022 26.30%
Jun 30, 2022 27.52%
Mar 31, 2022 24.45%
Dec 31, 2021 21.91%
Sep 30, 2021 21.68%
API Access

Eli Lilly Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY